New Results From Second Phase 3 Study Show Significant Efficacy Of Guselkumab And Superiority Versus Humira® In Treatment Of Moderate To Severe Plaque Psoriasis
- EMEA Innovative Medicine
- New Results From Second Phase 3 Study Show Significant Efficacy Of Guselkumab And Superiority Versus Humira® In Treatment Of Moderate To Severe Plaque Psoriasis
New Results From Second Phase 3 Study Show Significant Efficacy Of Guselkumab And Superiority Versus Humira® In Treatment Of Moderate To Severe Plaque Psoriasis
- X (Twitter)
Copy link